Endolumik

Executive Summary

Endolumik is a medical device company developing a fluorescence-guided gastric calibration system, the NIR Lighted Bougie, designed to enhance visualization during laparoscopic and robotic bariatric and foregut surgeries. By integrating near-infrared (NIR) light into the calibration tube, the device enables surgeons to see the tube's position through stomach tissue in real time, reducing the risk of perforation and improving surgical consistency and efficiency. The company is headquartered in Houston, Texas, and was founded in 2018, positioning itself in the growing market for minimally invasive surgical tools. The global bariatric surgery market is expanding, driven by rising obesity rates and increased adoption of minimally invasive procedures. Endolumik's product addresses a critical unmet need for better intraoperative visualization, potentially reducing complications that lead to costly revisions. If successfully commercialized, the device could become a standard adjunct in foregut surgeries. Key risks include regulatory hurdles and competition from established laparoscopic visualization technologies. However, the company's focus on a specific, high-value surgical step and early proof-of-concept data suggest meaningful potential for adoption.

Upcoming Catalysts (preview)

• Q4 2027FDA 510(k) Clearance for NIR Lighted Bougie60% success
• Q2 2028First Clinical Study Results50% success
• Q3 2027Strategic Partnership with Major Surgical Device Company40% success